Biggest News Aggregation in the World
📰 Phra News

Page 2 - Phra News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phra. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

United Kingdom's MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism

COPENHAGEN, Denmark, April 24, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for YORVIPATH® (palopegteriparatide; developed as TransCon™ PTH) in Great Britain as a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism, and has also granted YORVIPATH orphan drug sta...
United States United Kingdom Great Britain Ascendis Pharma Endocrine Society Guidelines European Commission
Source: yahoo.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science